UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) — Los Angeles, California

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) has participated in 4 clinical trials.

Therapeutic areas: ADHD, HIV, HIV Infections.

Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601)?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) conducted?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) has 4 clinical trials on record. Their work covers ADHD, HIV, HIV Infections.

Is UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) accredited by Crixeo Health?

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.